跳转至内容
Merck
CN

Bis dihydropyrimidine: synthesis and antimycobacterial activity.

Journal of enzyme inhibition and medicinal chemistry (2010-06-30)
Mohamed Ashraf Ali, Elumalai Manogaran, Jeyabalan Govindasamy, Velmurugan Sellappan, Suresh Pandian
摘要

A series of bis dihydropyrimidine compounds were synthesised by reacting dapsone with acetylacetoacetate to produce N1-4-[4-(2-oxopropylcarboxamido) phenylsulphonyl] phenyl-3-oxobutanamide, then treated with guanidine hydrochloride and an appropriate aldehyde with a catalytic amount of p-toluene sulphonic acid (PTSA) in the presence of methanol to afford the title compounds. The synthesised compounds were evaluated for their antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv and isoniazid (INH) resistant M. tuberculosis. Among the synthesised compounds, compound N5-(4-4-[6-(4-fluorophenyl)-2-imino-4-methyl-1,2,3,4-tetrahydro-5-pyrimidinylcarboxamido]phenylsulphonylphenyl)-6-(4-fluorophenyl)-2-imino-4-methyl-1,2,3,4-tetrahydro-5-pyrimidine carboxamide (3g) was found to be the most promising compound with activity against M. tuberculosis H(37)Rv and INH resistant M. tuberculosis with a minimum inhibitory concentration (MIC) between 0.08 and 0.10 μM.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
p-甲苯磺酸 一水合物, ACS reagent, ≥98.5%
Sigma-Aldrich
p-甲苯磺酸 一水合物, ReagentPlus®, ≥98%
Sigma-Aldrich
对甲苯磺酸钠, 95%
Sigma-Aldrich
对甲苯磺酸银, ≥99%